Do you want to read an article? Please log in or register.
Rivaroxaban vs Warfarin Sodium in the Ultra-Early Period After Atrial Fibrillation-Related Mild Ischemic Stroke: A Randomized Clinical Trial
Stroke
Related content
Stroke
Assessment of Shared Decision-making for Stroke Prevention in Patients With Atrial Fibrillation: A Randomized Clinical Trial.
JAMA Intern Med.
Kunneman M, Branda ME, Hargraves IG, Sivly AL, Lee AT, Gorr H, Burnett B, Suzuki T, Jackson EA, Hess E, Linzer M, Brand-McCarthy SR, Brito JP, Noseworthy PA, Montori VM, Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial Investigators.
doi: 10.1001/jamainternmed.
RECOMMENDED
Stroke
Risks of Stroke and Mortality in Atrial Fibrillation Patients Treated With Rivaroxaban and Warfarin
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Stroke.
Alberts M, Chen YW, Lin JH, Kogan E, Twyman K, Milentijevic D
doi: 10.1161/STROKEAHA.119.025554.
Stroke
Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial
JAMA.
Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, Fansler A, Van de Bruinhorst K, Janis S, Durkalski-Mauldin VL, Neurological Emergencies Treatment Trials Network and the SHINE Trial Investigators.
doi: 10.1001/jama.2019.9346.
Safety and Efficacy of a 3-Dimensional Stent Retriever With Aspiration-Based Thrombectomy vs Aspiration-Based Thrombectomy Alone in Acute Ischemic Stroke Intervention: A Randomized Clinical Trial
JAMA Neurol.
Nogueira RG, Frei D, Kirmani JF, Zaidat O, Lopes D, Turk AS 3rd, Heck D, Mason B, Haussen DC, Levy EI, Mehta S, Lazzaro M, Chen M, Dörfler A, Yoo AJ, Derdeyn CP, Schwamm L, Langer D, Siddiqui A; Penumbra Separator 3D Investigators
doi: 10.1001/
Stroke
Safety of Anticoagulation in Patients Treated With Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation
Stroke.
Giustozzi M, Acciarresi M, Agnelli G, Caso V, Bandini F, Tsivgoulis G, Yaghi S, Furie KL, Tadi P, Becattini C, Zedde M, Abdul-Rahim AH, Lees KR, Alberti A, Venti M, D'Amore C, Giulia Mosconi M, Anna Cimini L, Bovi P, Carletti M, Rigatelli A, Cappellari M, Putaala J, Tomppo L, Tatlisumak T, Marcheselli S, Pezzini A, Poli L, Padovani A, Vannucchi V, Sohn SI, Lorenzini G, Tassi R, Guideri F, Acampa M, Martini G, Ntaios G, Athanasakis G, Makaritsis K, Karagkiozi E, Vadikolias K, Liantinioti C, Theodorou A, Halvatsiotis P, Mumoli N, Galati F, Sacco S, Tiseo C, Corea F, Ageno W, Bellesini M, Silvestrelli G, Ciccone A, Lanari A, Scoditti U, Denti L, Mancuso M, Ferrari E, Ulivi L, Orlandi G, Giannini N, Tassinari T, Luisa De Lodovici M, Rueckert C, Baldi A, Toni D, Letteri F, Giuntini M, Maria Lotti E, Flomin Y, Pieroni A, Kargiotis O, Karapanayiotides T, Monaco S, Maimone Baronello M, Csiba L, Szabó L, Chiti A, Giorli E, Del Sette M, Imberti D, Zabzuni D, Doronin B, Volodina V, Michel P, Vanacker P, Barlinn K, Barlinn J, Deleu D, Gourbali V, Paciaroni M, Masotti L
doi: 10.1161/STROKEAHA.
RECOMMENDED
Stroke
Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation
Lancet Neurol.
Seiffge DJ, Werring DJ, Paciaroni M, Dawson J, Warach S, Milling TJ, Engelter ST, Fischer U, Norrving B
doi: 10.1016/S1474-
Stroke
Theophylline as an Add-On to Thrombolytic Therapy in Acute Ischemic Stroke: A Randomized Placebo-Controlled Trial
Stroke.
Modrau B, Andersen G, Mikkelsen IK, Nielsen A, Hansen MB, Johansen MB, Eskildsen HW, Povlsen JP, Yavarian Y, Mouridsen K, Østergaard L, Bach FW, Hjort N
doi: 10.1161/STROKEAHA.
Stroke
Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors
Stroke
Grimaldi-Bensouda L, Le Heuzey JY, Ferrières J, Leys D, Davy JM, Martinez M, Dialla O, Smadja D, Nighoghossian N, Benichou J, Nordon C, Touzé E, Abenhaim L, PGRx-Stroke and PGRx-Atrial Fibrillation Study Groups.
doi: 10.1161/STROKEAHA.120.032704
RECOMMENDED
Stroke
Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
JAMA.
Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, Yan B, Bush SJ, Thijs V, Scroop R, Simpson M, Brooks M, Asadi H, Wu TY, Shah DG, Wijeratne T, Zhao H, Alemseged F, Ng F, Bailey P, Rice H, de Villiers L, Dewey HM, Choi PMC, Brown H, Redmond K, Leggett D, Fink JN, Collecutt W, Kraemer T, Krause M, Cordato D, Field D, Ma H, O'Brien B, Clissold B, Miteff F, Clissold A, Cloud GC, Bolitho LE, Bonavia L, Bhattacharya A, Wright A, Mamun A, O'Rourke F, Worthington J, Wong AA, Levi CR, Bladin CF, Sharma G, Desmond PM, Parsons MW, Donnan GA, Davis SM, EXTEND-IA TNK Part 2 investigators.
doi: 10.1001/jama.2020.1511.